Home > Share Market > Stocks > Wockhardt > Financial Statements > WOCKPHARMA Key Financial Ratios

Wockhardt Financial Statements

WOCKPHARMA Ratio Analysis

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2022 Mar-2021 Mar-2020 Mar-2018
Growth matrix (%)        
Revenue growth 19.30 (4.80) (28) (1.90)
Op profit growth (573) (153) 6,404 (86)
EBIT growth (140) 167 141 25.50
Net profit growth (136) (1,091) (89) 211
Profitability ratios (%)        
OPM 9.23 (2.30) 4.19 0.05
EBIT margin 2.20 (6.50) (2.30) (0.70)
Net profit margin (7.60) 25.30 (2.40) (15)
RoCE 1.06 (2.60) (0.90) (0.40)
RoNW (1.70) 5.67 (0.60) (4.90)
RoA (0.90) 2.50 (0.20) (2)
Per share ratios ()        
EPS (19) 62.60 (3.90) --
Dividend per share -- -- -- --
Cash EPS (34) 39.70 (26) (69)
Book value per share 267 305 241 258
Valuation ratios        
P/E (14) 6.10 (41) --
P/CEPS (7.70) 9.61 (6) (9.80)
P/B 0.99 1.25 0.66 2.60
EV/EBIDTA 17.60 101 33.10 87.70
Payout (%)        
Dividend payout -- -- -- --
Tax payout (58) (64) (60) 9.08
Liquidity ratios        
Debtor days 104 146 142 92.60
Inventory days 88.60 100 99.20 91
Creditor days (108) (108) (104) (56)
Leverage ratios        
Interest coverage (0.20) 0.71 0.24 0.11
Net debt / equity 0.47 0.71 1.24 0.93
Net debt / op. profit 6.01 (38) 27.80 1,457
Cost breakup ()        
Material costs (39) (42) (42) (46)
Employee costs (23) (28) (26) (24)
Other costs (28) (32) (27) (30)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000